From the discovery of the first form of effective chemotherapy in 1949 to the genetically tailored cancer drugs of the 90s, treatment methods have evolved dramatically in the modern era thanks to decades of rigorous clinical trials.With the help of some of the world’s leading oncologists and cancer treatment specialists we’ve decided to produce a timeline which outlines 10 of the most important advances in clinical cancer research and pay tribute to the scientists and patients who organised and participated in them.We’ve also outlined 3 promising avenues of clinical research taking place today which are expected to yield encouraging results in the near future. Take a look at our timeline below to discover the trials and treatments which were chosen!We would like to thank the following people for their support on the project:Prof. Gareth Evans, Professor of Medical Genetics and Cancer Epidemiology The University of ManchesterProf. Tim Eisen, Clinical Director of Medical Oncology University of CambridgeDr. Susan Danson, Honorary Consultant in Medical Oncology at Weston Park HospitalProf. Margaret Knowles, Head of Section of Experimental Oncology Leeds Institute of Cancer and PathologyProf. Gillian Tozer, Department of Oncology, The University of Sheffield

No Triumph Without Trials

Find out more about our own clinical research studies here.

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event